Cannabinoid Receptor Type 1 (CB1) Agonists - Pipeline Insights, 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Cannabinoid Receptor Type 1 (CB1) Agonists - Pipeline Insights, 2017" drug pipelines to their offering.

Cannabinoid Receptor Type 1 (CB1) Agonists - Pipeline Insights, 2017 provides in depth insights on the pipeline drugs and their development activities around the Cannabinoid Receptor Type 1 (CB1) Agonists. This report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.

Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. This report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Cannabinoid Receptor Type 1 (CB1) Agonists.

This report also assesses the Cannabinoid Receptor Type 1 (CB1) Agonists therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Key Topics Covered:

  1. Cannabinoid Receptor Type 1 (CB1) Agonists Overview
  2. Cannabinoid Receptor Type 1 (CB1) Agonists Pipeline Therapeutics
  3. Cannabinoid Receptor Type 1 (CB1) Agonists Therapeutics under Development by Companies
  4. Cannabinoid Receptor Type 1 (CB1) Agonists Filed and Phase III Products
  5. Cannabinoid Receptor Type 1 (CB1) Agonists Phase II Products
  6. Cannabinoid Receptor Type 1 (CB1) Agonists Phase I and IND Filed Products
  7. Cannabinoid Receptor Type 1 (CB1) Agonists Discovery and Pre-Clinical Stage Products
  8. Drug Candidate Profiles
  9. Cannabinoid Receptor Type 1 (CB1) Agonists - Therapeutics Assessment
  10. Companies Involved in Therapeutics Development for Cannabinoid Receptor Type 1 (CB1) Agonists
  11. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/8432mh/cannabinoid

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs